Summary report on the ISOBM TD-6 workshop: analysis of 20 monoclonal antibodies against Sialyl Lewisa and related antigens. Montreux, Switzerland, September 19-24, 1997.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 9701730)

Published in Tumour Biol on January 01, 1998

Authors

P D Rye1, N V Bovin, E V Vlasova, A A Molodyk, A Baryshnikov, F T Kreutz, W I Garinther, B C Schultes, A A Noujaim, R Madiyalakan, J Magnani, O Nilsson, K Nilsson, K Nustad, L Norum, H Bell, Y Cao, M R Suresh, D L Very, J V Freeman, K K Yeung, J Hilgers

Author Affiliations

1: Central Laboratory, Norwegian Radium Hospital, Montebello, Oslo, Norway.

Articles by these authors

(truncated to the top 100)

Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol (1994) 22.96

The genome of black cottonwood, Populus trichocarpa (Torr. & Gray). Science (2006) 21.03

Body mass index reference curves for the UK, 1990. Arch Dis Child (1995) 16.96

Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer (1976) 14.08

Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science (1993) 13.87

Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell (1994) 13.76

Decay characteristics of HIV-1-infected compartments during combination therapy. Nature (1997) 13.68

Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science (1998) 12.05

British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood. Stat Med (1998) 10.09

Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science (1996) 7.73

Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science (2001) 7.66

Analysis of gene expression in single live neurons. Proc Natl Acad Sci U S A (1992) 6.15

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch (2006) 5.86

Genome sequence of the plant pathogen and biotechnology agent Agrobacterium tumefaciens C58. Science (2001) 5.16

Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. Proc Natl Acad Sci U S A (1974) 5.13

Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J Virol (1993) 4.83

A developmental switch sufficient for flower initiation in diverse plants. Nature (1995) 4.70

Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas. Int J Cancer (1976) 4.35

Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. J Virol (1995) 4.33

The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol (2007) 4.22

Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc Natl Acad Sci U S A (2000) 4.22

High serum S100B levels for trauma patients without head injuries. Neurosurgery (2001) 4.16

Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J (1997) 4.07

TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch (2007) 3.89

Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J Virol (1999) 3.79

Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. AIDS Res Hum Retroviruses (1996) 3.74

Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J Virol (2000) 3.54

A massive binary black-hole system in OJ 287 and a test of general relativity. Nature (2008) 3.50

Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines. J Exp Med (1976) 3.49

HIV-1 drug resistance in newly infected individuals. JAMA (1999) 3.49

A genetic framework for floral patterning. Nature (1998) 3.42

Modeling plasma virus concentration during primary HIV infection. J Theor Biol (2000) 3.40

Photoinduced conversion of silver nanospheres to nanoprisms. Science (2001) 3.39

Specification of receptor-binding phenotypes of influenza virus isolates from different hosts using synthetic sialylglycopolymers: non-egg-adapted human H1 and H3 influenza A and influenza B viruses share a common high binding affinity for 6'-sialyl(N-acetyllactosamine). Virology (1997) 3.33

Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1. J Virol (1994) 3.28

Detection of avian and mammalian oncogenic RNA viruses (oncornaviruses) by immunofluorescence. Cancer Res (1972) 3.23

Fasting capillary glucose as a screening test for gestational diabetes mellitus. BJOG (2006) 3.23

Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient. Clin Exp Immunol (1970) 3.17

Inter- and intraclade neutralization of human immunodeficiency virus type 1: genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes. J Virol (1996) 3.04

A primordial tRNA modification required for the evolution of life? EMBO J (2001) 3.01

The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV. Int J Cancer (1971) 2.96

Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. Clin Chem (1991) 2.96

A complex of platelet glycoproteins Ic and IIa identified by a rat monoclonal antibody. J Biol Chem (1987) 2.94

Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc Natl Acad Sci U S A (1997) 2.88

K562--a human erythroleukemic cell line. Int J Cancer (1979) 2.84

Spinal cord repair in adult paraplegic rats: partial restoration of hind limb function. Science (1996) 2.83

Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature (2001) 2.83

Phenotypic and cytogenetic characteristics of human B-lymphoid cell lines and their relevance for the etiology of Burkitt's lymphoma. Adv Cancer Res (1982) 2.68

Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from patients treated with the protease inhibitor nelfinavir. Antimicrob Agents Chemother (1998) 2.67

Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines. J Virol (1998) 2.63

Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1. J Virol (1997) 2.60

HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy. J Exp Med (1998) 2.50

Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology (2005) 2.49

HIV-1 subtype and second-receptor use. Nature (1996) 2.46

Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement. J Virol (1996) 2.45

HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy. J Clin Invest (1999) 2.42

High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J Natl Cancer Inst (2000) 2.41

Characterization and properties of nine human ovarian adenocarcinoma cell lines. Cancer Res (1988) 2.40

Exploration of antigenic variation in gp120 from clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies. J Virol (1994) 2.36

Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet (1998) 2.31

Angiogenesis inhibited by drinking tea. Nature (1999) 2.31

Probing of the receptor-binding sites of the H1 and H3 influenza A and influenza B virus hemagglutinins by synthetic and natural sialosides. Virology (1993) 2.27

The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses. J Infect Dis (1999) 2.27

Gelatinase biosynthesis-activating pheromone: a peptide lactone that mediates a quorum sensing in Enterococcus faecalis. Mol Microbiol (2001) 2.22

Classification and biological nature of established human hematopoietic cell lines. Int J Cancer (1975) 2.16

Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors. Int J Cancer (1984) 2.12

Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci U S A (2001) 2.11

Susceptibility to infection by the human immunodeficiency virus (HIV) correlates with T4 expression in a parental monocytoid cell line and its subclones. Virology (1987) 2.11

Retroposon analysis of major cetacean lineages: the monophyly of toothed whales and the paraphyly of river dolphins. Proc Natl Acad Sci U S A (2001) 2.11

Epstein-Barr virus-associated complement-fixing and nuclear antigens in Burkitt lymphoma biopsies. Int J Cancer (1974) 2.10

Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression. J Clin Invest (1991) 2.08

Phorbol ester-induced differentiation of chronic lymphocytic leukaemia cells. Nature (1980) 2.08

High-frequency establishment of human immunoglobulin-producing lymphoblastoid lines from normal and malignant lymphoid tissue and peripheral blood. Int J Cancer (1971) 2.06

Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening. J Med Chem (2001) 2.06

[Genetic diagnostic test for hemochromatosis]. Tidsskr Nor Laegeforen (1998) 2.02

Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q. Genomics (1999) 1.99

Genetic analysis of human immunodeficiency virus type 1 strains from patients in Cyprus: identification of a new subtype designated subtype I. J Virol (1995) 1.98

Adaptation of two primary human immunodeficiency virus type 1 isolates to growth in transformed T cell lines correlates with alterations in the responses of their envelope glycoproteins to soluble CD4. AIDS Res Hum Retroviruses (1993) 1.94

A LEAFY co-regulator encoded by UNUSUAL FLORAL ORGANS. Curr Biol (1997) 1.93

Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer. J Urol (1993) 1.91

MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation. Leuk Res (1999) 1.90

Interventions during pregnancy to reduce excessive gestational weight gain: a systematic review assessing current clinical evidence using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system. BJOG (2010) 1.89

Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur J Cancer (2003) 1.86

Tumorigenicity of human hematopoietic cell lines in athymic nude mice. Int J Cancer (1977) 1.84

Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung. Am J Respir Crit Care Med (1997) 1.83

A retrospective study of the application on double-balloon enteroscopy in 378 patients with suspected small-bowel diseases. Endoscopy (2007) 1.81

Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy. J Intern Med (2002) 1.80

Variations among sublines of inbred AKR mice. Nat New Biol (1973) 1.78

Idiopathic CD4+ T-lymphocytopenia--immunodeficiency without evidence of HIV infection. N Engl J Med (1993) 1.77

Preponderance of slightly deleterious polymorphism in mitochondrial DNA: nonsynonymous/synonymous rate ratio is much higher within species than between species. Mol Biol Evol (1998) 1.76

Nasal continuous positive airway pressure: experiences with a new technical approach. Acta Paediatr (1993) 1.74

Transfer RNA modification: influence on translational frameshifting and metabolism. FEBS Lett (1999) 1.73

Phenotypic characterization of the human mast-cell line HMC-1. Scand J Immunol (1994) 1.73

H-2-linked control of in vitro gamma interferon production in response to a 32-kilodalton antigen (P32) of Mycobacterium bovis bacillus Calmette-Guérin. Infect Immun (1988) 1.73

Establishment and characteristics of two unique cell lines from patients with lymphosarcoma. Int J Cancer (1974) 1.73

The multifaceted roles of FLOWERING LOCUS T in plant development. Plant Cell Environ (2012) 1.72

Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease. J Neurochem (1982) 1.72

Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer. J Urol (2000) 1.72

The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor. Oncogene (2001) 1.72

Nitric oxide is involved in phosphorus deficiency-induced cluster-root development and citrate exudation in white lupin. New Phytol (2010) 1.71